BioSig Technologies, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 4/28/2017
Contact Info
  • 8441 Wayzata Blvd.
  • Suite 240
  • Minneapolis, MN 55426

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001530766
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3845 - Electromedical equipment
Incorporated In: DE, USA
Year of Inc. 2009
Employees 14 a/o Mar 31, 2017
Company Officers/Contacts
Kenneth L Londoner CEO
Steve Chaussy CFO
Company Directors
Kenneth L Londoner Chairman
Seth H. Z. Fischer Independent Director, Compensation Committee Member
Donald E. Foley Independent Director, Nominating Committee Member
Patrick J. Gallagher Independent Director, Audit Committee Member
David Weild IV Independent Director, Audit Committee Member
Jeffrey F. O'Donnell, Sr. Independent Director, Audit Committee Member, Compensation Committee Member
Roy T Tanaka Independent Director, Compensation Committee Member, Nominating Committee Member
Jerome B. Zeldis Independent Director, Nominating Committee Member
Service Providers
Accounting/Auditing Firm
Liggett & Webb, P.A.
432 Park Avenue South, 10 Floor
New York, NY, 10016
United States
Securities Counsel
Haynes and Boone, LLP OTCQX Sponsor
30 Rockefeller Plaza
26th Floor
New York, NY, 10510
United States
Investor Relations Firm
IRTH Communications, LLC
520 Broadway
Suite 350
Santa Monica, CA, 90401
United States
BSGM Security Details
Share Structure
Market Value1 $42,005,646 a/o Oct 19, 2017
Authorized Shares 200,000,000 a/o Oct 11, 2017
Outstanding Shares 25,929,411 a/o Oct 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 11,886,823 a/o Oct 11, 2017
Par Value 0.001
Shareholders of Record 217 a/o Oct 11, 2017
Short Selling Data
Short Interest 20,725 (20.55%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security